Patents for C12R 1 - Micro-organisms (92,025) |
---|
03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
03/06/1996 | EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
03/06/1996 | EP0699761A2 Heptaprenyl diphosphate synthesizing enzyme and dna encoding same |
03/06/1996 | EP0699760A1 Purified DNA polymerase from bacillus stearothermophilus |
03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
03/06/1996 | EP0699757A1 Potyvirus coat protein genes and plants transformed therewith |
03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
03/06/1996 | EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses |
03/06/1996 | EP0699749A1 Recombinant cycloisomaltooligosaccharide synthase, DNA encoding it, and its use |
03/06/1996 | EP0699748A2 Decreased hydrogen sulfide formation in beer production |
03/06/1996 | EP0699689A1 Branched polysaccharide, microorganism producing it and compositions containing them |
03/06/1996 | EP0699682A1 Process for the preparation and/or purification of clavulanic acid |
03/06/1996 | EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
03/06/1996 | EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
03/06/1996 | EP0699076A1 Otitis media vaccine |
03/06/1996 | EP0620853B1 Materials and methods for biosynthesis of serine and serine-related products |
03/06/1996 | EP0516817B1 Method and medium for detecting salmonella |
03/06/1996 | EP0505397B1 Method of making factor-dependent human b cell lines |
03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
03/06/1996 | EP0387319B1 Secretory leader sequences |
03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
03/06/1996 | EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same |
03/06/1996 | CN1118131A An enzyme feed additive and animal feed including it |
03/06/1996 | CN1118007A Low-temperature inactive industrial baker's yeast |
03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
03/05/1996 | US5496931 Insecticide and miticide A83543 compounds and their method of production by fermentation |
03/05/1996 | US5496729 Contacting with aqueous phase containing bacterial organism or bacterial cell-free fractions as biocatalyst with sulfur-specific c-s bond cleavage ability, allowing cleavage and solubilization of inorganic salts and sulfur compounds |
03/05/1996 | US5496727 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
03/05/1996 | US5496726 Streptococcus zooepidemicus medium and process for preparing hyaluronic acid |
03/05/1996 | US5496724 Genes encoding platelet aggregation inhibitors |
03/05/1996 | US5496723 Inoculation for pollution control and culture of acinetobacter with nutrients |
03/05/1996 | US5496709 Process for production of canthaxanthin |
03/05/1996 | US5496706 Methods and materials for the detection of Staphylococcus aureus |
03/05/1996 | US5496547 Pseudomonas biocontrol strains |
03/05/1996 | CA1338122C Tissue factor inhibitor of coagulation |
03/03/1996 | CA2157345A1 Method of detecting organopathy-inducing factors |
02/29/1996 | WO1996006188A1 Peptide librairies as a source of syngenes |
02/29/1996 | WO1996006183A1 Culture medium and device for detection and enumeration of enterobacteriaceae |
02/29/1996 | WO1996006182A1 Culture medium for rapid count of coliform bacteria |
02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
02/29/1996 | WO1996006175A2 Fumonisin-detoxifying enzymes |
02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
02/29/1996 | WO1996006171A2 New polypetides having a toxic activity against insects of the dipterae family |
02/29/1996 | WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor |
02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
02/29/1996 | WO1996006167A1 Glutamate receptor |
02/29/1996 | WO1996006165A1 Genetically engineered swine cells |
02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
02/29/1996 | WO1996006113A1 New immunocontraceptive peptides |
02/29/1996 | WO1996005859A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
02/29/1996 | WO1996001614A3 Rna component of telomerase |
02/29/1996 | WO1996001324A3 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
02/29/1996 | CA2198265A1 New immunocontraceptive peptides |
02/29/1996 | CA2198206A1 Human chemokine beta-9 |
02/29/1996 | CA2197864A1 Peptide libraries as a source of syngenes |
02/29/1996 | CA2197650A1 Method of treating birds with avian myelomonocytic growth factor |
02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
02/29/1996 | CA2196997A1 Glutamate receptor |
02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
02/29/1996 | CA2196311A1 Genetically engineered swine cells |
02/28/1996 | EP0698667A1 Xylanase, microorganisms for its production, DNA molecules, process of preparation and use thereof |
02/28/1996 | EP0698665A2 Infectious Tick-Borne Encephalitis virus cDNA clone, recombinant vaccine derived therefrom and preparation thereof |
02/28/1996 | EP0698664A1 Alpha-1,3/4 fucosidase gene |
02/28/1996 | EP0698663A1 A novel restriction endonuclease |
02/28/1996 | EP0698347A2 Food composition containing reuterin |
02/28/1996 | EP0698120A1 Culture medium for rapid count of coliform bacteria |
02/28/1996 | EP0698117A1 Monoclonal antibodies against ck-mb |
02/28/1996 | EP0698116A1 Processes for producing an enzyme |
02/28/1996 | EP0698110A1 Process for demethylating dimethylsulphonium compounds |
02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
02/28/1996 | EP0698107A1 Gene therapy for haemophilia |
02/28/1996 | EP0698106A1 Marker gene |
02/28/1996 | EP0698105A1 Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
02/28/1996 | EP0698103A1 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
02/28/1996 | EP0698102A1 Cholesterol-oxidase from brevibacterium sterolicum |
02/28/1996 | EP0698095A1 Bmp-10 compositions |
02/28/1996 | EP0698094A1 Bmp-11 compositions |
02/28/1996 | EP0698089A1 Nucleic acid encoding amp-activated protein kinase |
02/28/1996 | EP0698088A1 L-amino acid oxidase |
02/28/1996 | EP0698086A1 Yeast strain and methods for expressing heterologous proteins in yeast |
02/28/1996 | EP0698042A1 Composition of antibodies against hepatitis b surface antigen |
02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
02/28/1996 | EP0697857A1 Hookworm anticoagulant |
02/28/1996 | EP0549710B1 A process for the preparation of enantiomeric 2-alkanoic acids |
02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
02/28/1996 | EP0362367B1 Osteogenic devices |
02/28/1996 | CN1117743A Method to predict active growth of bacteria adhered to a surface |
02/28/1996 | CN1117526A Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant hepatitus B virus surface antigen |
02/28/1996 | CN1117349A Immobilised beta-mannanase |
02/27/1996 | US5495071 Genetic engineering |
02/27/1996 | US5495008 Oligonucleotide probes for detection of salmonella |
02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
02/27/1996 | US5494931 Anticoccidial in poultry, preventing and treating swine dysentery, growth promoter in cattle and swine |
02/27/1996 | US5494820 Streptomyces braegensis strain and its cultivation in a process for producing C9 -desoxo-FK-520 |
02/27/1996 | US5494818 A fusion protein encoded by the dna which specifically cleaves in vitro between c-terminal residue of ubiquitin and n-terminal residue of protein |